NCT07770256

Brief Summary

This study consists of two components evaluating furcation involvement in mandibular molars among Stage III or Stage IV periodontitis patients. Component 1 is a cross-sectional study evaluating the prevalence and morphological characteristics of Hamp Class II furcation defects during initial screening. Component 2 is a randomized controlled clinical trial in 30 selected patients comparing the diagnostic accuracy of Cone Beam Computed Tomography (CBCT) against direct intra-operative clinical measurements, as well as evaluating the clinical and radiographic outcomes of regenerative periodontal surgery using Acellular Dermal Matrix (ADM) + Enamel Matrix Derivative (EMD) + Xenograft versus Autogenous Connective Tissue Graft (CTG) + EMD + Xenograft.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for not_applicable

Timeline
19mo left

Started May 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
May 2026May 2028

Study Start

First participant enrolled

May 2, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 11, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 18, 2026

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2028

Last Updated

August 18, 2026

Status Verified

August 1, 2026

Enrollment Period

1.6 years

First QC Date

August 11, 2026

Last Update Submit

August 14, 2026

Conditions

Keywords

Periodontal RegenerationConnective Tissue GraftEnamel Matrix DerivativeAcellular Dermal MatrixCone-Beam Computed Tomography

Outcome Measures

Primary Outcomes (3)

  • Change in Probing Pocket Depth (PPD)

    Reduction in probing pocket depth measured in millimeters (mm) at the furcation defect site from the gingival margin to the bottom of the pocket using a UNC-15 probe.

    Baseline and 6 months post-operatively

  • Change in Clinical Attachment Level (CAL)

    Gain in clinical attachment level measured in millimeters (mm) at the furcation defect site from the cementoenamel junction (CEJ).

    Baseline and 6 months post-operatively

  • Prevalence and Morphological Distribution of Furcation Involvement

    Prevalence of furcation defects in mandibular molars among Stage III/IV periodontitis patients and classification of defect severity according to Hamp's classification (Class I, II, and III).

    Baseline (Screening Phase)

Secondary Outcomes (6)

  • Change in Radiographic Vertical Bone Level on CBCT (CEJ-B)

    Baseline and 6 months post-operatively

  • Change in Radiographic Horizontal Bone Loss on CBCT (H-BL)

    Baseline and 6 months post-operatively

  • Change in Gingival Recession (GR)

    Baseline, 1 month, 3 months, and 6 months post-operatively

  • Change in Gingival Thickness (GT)

    Baseline, 1 month, 3 months, and 6 months post-operatively

  • Change in Keratinized Tissue Height (KTH)

    Baseline, 1 month, 3 months, and 6 months post-operatively

  • +1 more secondary outcomes

Study Arms (2)

ADM + EMD + Xenograft

EXPERIMENTAL

Patients with Hamp Class II furcation defects receive open flap debridement and regenerative periodontal surgery using Acellular Dermal Matrix (ADM) combined with Enamel Matrix Derivative (EMD) and xenograft.

Procedure: Acellular Dermal Matrix + EMD + Xenograft

CTG + EMD + Xenograft

ACTIVE COMPARATOR

Patients with Hamp Class II furcation defects receive open flap debridement and regenerative periodontal surgery using autogenous Connective Tissue Graft (CTG) combined with Enamel Matrix Derivative (EMD) and xenograft.

Procedure: Autogenous Connective Tissue Graft + EMD + Xenograft

Interventions

Surgical debridement of furcation defect, application of Enamel Matrix Derivative (EMD), placement of xenograft, and coverage with Acellular Dermal Matrix (ADM).

ADM + EMD + Xenograft

Surgical debridement of furcation defect, harvesting autogenous connective tissue graft from the palate, application of Enamel Matrix Derivative (EMD), placement of xenograft, and coverage with CTG.

CTG + EMD + Xenograft

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 years or older who signed the informed consent form.
  • Diagnosed with Stage III or Stage IV periodontitis according to the 2017 AAP/EFP classification.
  • Completed non-surgical periodontal therapy with full-mouth plaque score (FMPS) and bleeding on probing (FMBS) \<= 20%.
  • Presence of at least one mandibular molar with Hamp Class II furcation involvement (horizontal bone loss \> 3 mm without through-and-through communication).
  • Target tooth requirements:
  • Probing pocket depth (PPD) \>= 5 mm.
  • Clinical attachment loss (CAL) \>= 3 mm.
  • Tooth mobility \<= Grade I (Miller index).
  • Vital pulp or adequately filled root canal treatment without periapical radiolucency.
  • Gingival margin positioned coronal to the furcation entrance.
  • Intact tooth structure without root fractures or furcation caries.

You may not qualify if:

  • Uncontrolled systemic diseases (e.g., uncontrolled diabetes, hypertension, cardiovascular disease, severe osteoporosis).
  • Pregnant or lactating women.
  • Current smokers or individuals who quit smoking less than 6 months prior to enrollment.
  • Use of antibiotics, anti-inflammatory agents, or medications affecting bone metabolism (e.g., bisphosphonates, high-dose corticosteroids, anti-resorptive drugs) within the past 3 months.
  • Previous periodontal surgery at the evaluation site within the past 6 months.
  • Target teeth presenting with:
  • Miller Grade II or Grade III tooth mobility.
  • Severe bone destruction extending to the root apex.
  • Metallic restorations (metal crowns, amalgam fillings, or large metallic posts) causing significant scatter/artifacts on CBCT scans.
  • Fused roots or abnormal root anatomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dental Clinic, Faculty of Odonto-Stomatology, University of Medicine and Pharmacy at Ho Chi Minh City

Ho Chi Minh City, 700000, Vietnam

RECRUITING

MeSH Terms

Conditions

PeriodontitisFurcation Defects

Interventions

emerinTransplantation, Heterologous

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

TransplantationSurgical Procedures, Operative

Central Study Contacts

Nguyen Trung Hung, MSc, DDS

CONTACT

Nga Tran Yen, PhD, DDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Candidate, Faculty of Odonto-Stomatology

Study Record Dates

First Submitted

August 11, 2026

First Posted

August 18, 2026

Study Start

May 2, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

May 1, 2028

Last Updated

August 18, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be made publicly available to protect participant privacy and confidentiality, in accordance with the protocol approved by the Ethics Committee. De-identified aggregate data and main findings will be published in the doctoral dissertation and peer-reviewed scientific journals.

Locations